Articles From: Imperium Renewables And Umpqua Bank Expand Lending Relationship to IMRIS CEO Jay D. Miller to present at InvestMNt 2014 Conference


Leading Biofuel Producer Gains Access to Additional $10M in Working Capital PORTLAND, Ore.
Sign-up for Imperium Renewables And Umpqua Bank Expand Lending Relationship investment picks
Imperva , Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced financial results for the second quarter ended June 30, 2014.
Sign-up for Imperva Announces Second Quarter 2014 Financial Results investment picks
Imperva, Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced that its board of directors has appointed Anthony J.
Sign-up for Imperva Appoints Anthony J. Bettencourt As New President and CEO investment picks
Imperva, Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced the appointment of Michael D.
Sign-up for Imperva Names Mike Mooney to New Role of Chief Revenue Officer investment picks
Imperva , Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced scheduled participation at the Deutsche Bank Technology Conference in Las Vegas, NV.
Sign-up for Imperva to Present at the Deutsche Bank Technology Conference investment picks
Imperva , Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced scheduled participation at the following upcoming conferences: A live webcast, as well as the replay, of these presentations will be accessible from the investors page of Imperva’s website at www.imperva.com .
Sign-up for Imperva to Present at Upcoming Conferences investment picks
Glenn Bolduc joins President Barack Obama, African leaders, and leading U.S. and African CEOs in an event focused on strengthening commercial and business ties between the U.S. and Africa WILMINGTON, Mass.
Sign-up for Implant Sciences CEO Invited to Attend Inaugural U.S.-Africa Business Forum by U.S. Department of Commerce investment picks
WILMINGTON, Mass.
Sign-up for Implant Sciences Responds to Levi & Korsinsky, LLP Press Release /Solicitation investment picks
Applications include air cargo, airport screening, and building security WILMINGTON, Mass.
Sign-up for Implant Sciences Ships $550,000 in Explosives Trace Detectors to Domestic and International Customers investment picks
2012/12/10
If you're looking to establish a sane, sustainable withdrawal plan, then follow these tips.
Sign-up for Implementing a Total-Return Approach to Retirement Income investment picks
2014/01/30
If you're looking to establish a sane, sustainable withdrawal plan, then follow these tips.
Sign-up for Implementing a Total-Return Approach to Retirement Income investment picks
2014/9/18
Important Safety Notice: Recall of Everyday Essentials™ Glass Mugs Canada NewsWire BRAMPTON, ON , Sept.
Sign-up for Important Safety Notice: Recall of Everyday Essentials™ Glass Mugs investment picks
SAN DIEGO , Sept.
Sign-up for Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference investment picks
- Imprimis' proprietary ophthalmic compounded formulations now available by prescription in 32 states and territories - SAN DIEGO , July 24, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY) , a vertically-integrated specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations, announced today that two Key Opinion Leader (KOL) presentations that describe the benefits of dropless cataract surgery formulations will be delivered at the upcoming American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium in Deer Valley, Utah from July 24 – 27, 2014.
Sign-up for Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium investment picks
VMworld ® (booth #316) — Imprivata ® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today introduced several technology enhancements to Imprivata OneSign Secure Walk-Away ® , the company’s biometric verification solution that safeguards against unauthorized access to patient records at unattended clinical workstations.
Sign-up for Imprivata Introduces Advanced Biometric Verification Solution to Safeguard against Unauthorized Access to Patient Information on Unattended Clinical Workstations investment picks
Within the next two years, 84 percent of organizations adopting Virtual Desktop Infrastructure (VDI) plan to implement single sign-on (SSO), according to new research from Imprivata ® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry.
Sign-up for Imprivata Survey of 335 U.S Hospitals Confirms that Rapid Adoption of Desktop Virtualization with Single Sign-On is Critical to Success investment picks
Imprivata ® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today announced that the company will release the results for its second quarter ended June 30, 2014 after the market closes on Monday, August 4, 2014.
Sign-up for Imprivata to Release Q2 2014 Financial Results on August 4, 2014 investment picks
Imprivata® (NYSE: IMPR), a leading provider of authentication and access management solutions for the healthcare industry, today announced financial results for the second quarter of fiscal 2014.
Sign-up for Imprivata, Inc. Reports Second Quarter 2014 Financial Results investment picks
RA'ANANA, Israel , August 12, 2014 /PRNewswire/ -- NICE Systems (NASDAQ: NICE) today announced a webinar series that will help organizations understand how they can now transform their contact center into a real-time engagement center.
Sign-up for Improve Your Reactions with Real Time: NICE to Present New NICE Engage Platform During Upcoming Webinar Series investment picks
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that researchers presented new data from an integrated analysis of survival from two open-label, Phase 2 studies of asfotase alfa in pediatric patients (ages ≤5 years at enrollment) with hypophosphatasia (HPP) compared with data from a retrospective natural history study of untreated historical control patients matched for age and disease severity.
Sign-up for Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated with Investigational Asfotase Alfa for Up to Five Years investment picks
2014/8/26
Improving Patient Safety and Saving Health Care Dollars: Pharmacists Can Play Key Role in Reducing Drug Therapy Problems Canada NewsWire TORONTO , Aug.
Sign-up for Improving Patient Safety and Saving Health Care Dollars: Pharmacists Can Play Key Role in Reducing Drug Therapy Problems investment picks
2014/10/9
Imricor Medical Systems Announces First Procedures in Clinical Study of MR-Enabled™Cardiac Ablation Products Canada NewsWire First patients treated with Vision-MR ™ Ablation Catheters MINNEAPOLIS , Oct.
Sign-up for Imricor Medical Systems Announces First Procedures in Clinical Study of MR-Enabled™Cardiac Ablation Products investment picks
2014/8/29
IMRIS Announces Receipt of Nasdaq Notice of Bid Price Deficiency Canada NewsWire WINNIPEG AND MINNEAPOLIS, MN , Aug.
Sign-up for IMRIS Announces Receipt of Nasdaq Notice of Bid Price Deficiency investment picks
2014/8/29
WINNIPEG AND MINNEAPOLIS, MN , Aug.
Sign-up for IMRIS Announces Receipt of Nasdaq Notice of Bid Price Deficiency investment picks
2014/9/24
MINNEAPOLIS , Sept.
Sign-up for IMRIS Announces Waiver and Amendment Agreement and Repricing of Warrants investment picks
2014/7/31
WINNIPEG, MB and MIINNEAPOLIS, MN, July 31, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the InvestMNt 2014 Conference in Minneapolis at 8:15 AM Central Time on Wednesday, August 6, 2014 .
Sign-up for IMRIS CEO Jay D. Miller to present at InvestMNt 2014 Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Imperium Renewables And Umpqua Bank Expand Lending Relationship to IMRIS CEO Jay D. Miller to present at InvestMNt 2014 Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices